- Filter:
- All
- News
- White Papers
- Articles
- Peer-reviewed Work
Intentional Nonadherence in Cancer Treatment Implementation
Monday, November 17, 2025
Atlantis Health co-authored a poster presented at ESPACOMP 2025. From global oncology patient research conducted in 2024, we describe four behavioral factors driving intentional nonadherence to self-administered cancer treatment, supporting the development of personalized adherence interventions using psychological approaches.
Case Study: Supporting Neovascular Age-Related Macular Degeneration (nAMD) patients to continue treatment
Wednesday, November 12, 2025
Overview of a patient support program designed to improve treatment outcomes and beliefs for people with neovascular age-related macular degeneration (nAMD).
Improving Outcomes: Empowering People to Manage Treatment and Health Conditions
Wednesday, November 12, 2025
A behavioral science approach to designing effective and engaging solutions that support people living with long-term conditions
Optimizing self-administered treatment initiation
Tuesday, October 28, 2025
Overview of a personalized patient engagement approach to treatment initiation with self-administered, device-delivered medications
Case Study: Enabling diagnosis acceptance and shared decision-making through personalized treatment onboarding
Tuesday, October 7, 2025
Overview of a Diagnosis Acceptance solution tailored for people living with Type 2 Diabetes.
Every Story Matters: Emotional realities and practical challenges of people living with cancer
Wednesday, October 1, 2025
Overview of the emotional and physical experiences of those living with cancer, from our 2025 Global Oncology Patient Nonadherence Study.
Case Study: Empowering people living with acute coronary syndrome taking oral anti-platelet medication
Monday, September 29, 2025
Overview of the approach and outcomes of the OneHeart patient support program for people living with acute coronary syndrome (ACS).
Case Study: Activating and empowering asthma control through simple self-assessment
Tuesday, September 23, 2025
Overview of an Activation solution tailored for people living with uncontrolled asthma.